Title |
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies |
|---|---|
Involved |
Cornelis M. van Tilburg (Verfasser)
Ruth Witt (Verfasser) Melanie Heiss (Verfasser) Kristian Wilfried Pajtler (Verfasser)
Christoph Plass (Verfasser)
Isabel Poschke (Verfasser) Michael Platten (Verfasser) Inga Harting (Verfasser) Oliver Sedlaczek (Verfasser) Angelika Freitag (Verfasser) David Meyrath (Verfasser) Lenka Taylor (Verfasser) Gnana Prakash Balasubramanian (Verfasser) Natalie Jäger (Verfasser) Elke Pfaff (Verfasser) Barbara Christine Jones (Verfasser) Till Milde (Verfasser) Stefan Pfister (Verfasser) David T. W. Jones (Verfasser) Annette Kopp-Schneider (Verfasser) Olaf Witt (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
BMC cancer 20, 1, 5.6.2020, date:12.2020, Seite 1-11 |
Published |
2020 |
Language |
|
Country |
|
Topic |
|
Subject |
Cancer Research.
Oncology. Surgical Oncology. Health Promotion and Disease Prevention.
Biomedicine, general.
Medicine/Public Health, general. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2020080702515156345914 (URN) |
Record ID |
1215336691 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: